Intra-Articular Ketorolac Injection into the Shoulder Joint
Yes, you can inject ketorolac (Toradol) into the shoulder joint—it is a safe and effective alternative to corticosteroids for managing shoulder pain from conditions like subacromial impingement, adhesive capsulitis, and inflammatory arthritis, with comparable analgesic efficacy and potentially fewer systemic side effects. 1, 2, 3
Evidence Supporting Intra-Articular Ketorolac Use
Efficacy in Shoulder Conditions
Subacromial impingement syndrome: A randomized trial demonstrated that 60 mg ketorolac injection produced equivalent pain reduction and functional improvement compared to 40 mg methylprednisolone at 1 and 3 months follow-up, with both groups showing statistically significant improvements in visual analog scale scores and range of motion. 3
Adhesive capsulitis (frozen shoulder): Ketorolac injection with capsular distension (using 19 mL of 0.5% lidocaine plus 30 mg ketorolac) showed comparable pain relief and functional improvement to steroid injection alone, with superior improvement in passive shoulder abduction and external rotation at 3 and 6 months. 2
Post-arthroscopy pain: Adding ketorolac to a multimodal intra-articular injection regimen (with ropivacaine, morphine, and triamcinolone) significantly reduced pain scores at 3,6,12,24, and 48 hours post-operatively, decreased rescue analgesic requirements (11.40 mg vs 16.57 mg morphine), and delayed time to first analgesic request (16.50 hours vs 8.9 hours). 1
Comparative effectiveness: In adhesive capsulitis, intra-articular ketorolac demonstrated significantly better pain reduction on the UCLA shoulder rating scale compared to hyaluronic acid at 4 weeks follow-up. 4
Procedural Considerations Based on Guidelines
Mandatory Requirements
Strict aseptic technique is non-negotiable when performing any intra-articular injection, including ketorolac, as the risk of septic arthritis—though low at 0.035% (approximately 1 in 2,857 procedures)—can be catastrophic. 5
The procedure must be performed in a professional, clean, quiet, private, and well-lit room with the patient positioned supine on an examination table. 6
All aseptic equipment and resuscitation equipment must be readily available before beginning the procedure. 6
Technical Approach
Ultrasound guidance improves injection accuracy and reduces procedural pain but is not mandatory for shoulder injections (unlike hip injections where imaging guidance is strongly recommended). 6
Offer local anesthetic (topical or infiltrative) and explain its benefits and risks to the patient before the procedure. 5, 6
Assistance from another qualified healthcare professional is optimal during the injection procedure. 6
Safety Profile and Contraindications
Relative Advantages Over Corticosteroids
Ketorolac avoids the systemic effects of glucocorticoids, making it particularly valuable in patients with diabetes (who would otherwise face transient hyperglycemia peaking on days 1-3 post-injection), those requiring frequent injections, or patients with contraindications to corticosteroids. 5, 6, 7
No evidence of cartilage damage has been reported with ketorolac injections, unlike concerns raised with repeated corticosteroid injections every 3 months showing conflicting data on cartilage volume loss. 6, 7
Contraindications and Precautions
Do not inject within 3 months before planned shoulder arthroplasty, as this timing increases postoperative infection risk (though this guideline is primarily established for corticosteroids, the same precaution should apply). 5, 6
Anticoagulation is not an absolute contraindication unless the patient has high bleeding risk; ketorolac's antiplatelet effects warrant consideration but do not preclude injection in most anticoagulated patients. 5, 6
Avoid in patients with active infection, severe renal impairment, or peptic ulcer disease, as these are standard NSAID contraindications. 7
Confirm a definitive diagnosis before injection—never use intra-articular injection as a diagnostic tool without first excluding infection. 6
Post-Injection Care
Patients should avoid overuse of the injected shoulder for the first 24 hours, but immobilization or splinting is discouraged as it provides no additional benefit. 6
Normal activity may resume after 24 hours without restriction. 6
Clinical Bottom Line
Intra-articular ketorolac injection is a legitimate, evidence-based alternative to corticosteroid injection for shoulder pathology, particularly valuable in patients with diabetes, those requiring repeated injections, or when corticosteroid side effects are a concern. 1, 2, 7, 3 The same rigorous aseptic technique and procedural standards that apply to corticosteroid injections must be followed. 5, 6 Multiple randomized trials demonstrate equivalent or superior outcomes compared to corticosteroids for shoulder impingement and adhesive capsulitis, with a potentially safer systemic profile. 2, 3